-
Cytokinetics' (CYTK) "Buy" Rating Reiterated at Needham & Company LLC
Source: Buzz FX / 07 Feb 2025 13:01:09 America/Chicago
Cytokinetics' (CYTK) "Buy" Rating Reiterated at Needham & Company LLC Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Cytokinetics ( NASDAQ:CYTK - Get Free Report ) 's stock had its "buy" rating restated by investment
Read more...